Advanced Breast Cancer Clinical Trials in Nanjing, Jiangsu
3 recruitingNanjing, Jiangsu, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Efficacy and Safety of Ribociclib Combined With AI Versus Physician&Amp;#39;s Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel)
Advanced Breast Cancer
The First Affiliated Hospital with Nanjing Medical University190 enrolled1 locationNCT06656624
Recruiting
Phase 2
Efficacy and Safety of Ribociclib in Combination With NSAI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in HR+/HER2- Advanced Breast Cancer
Advanced Breast Cancer
The First Affiliated Hospital with Nanjing Medical University144 enrolled1 locationNCT06375707
Recruiting
Phase 2
Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy
Advanced Breast CancerObjective Response RateTrastuzumab Emtansine
The First Affiliated Hospital with Nanjing Medical University36 enrolled1 locationNCT06125834